Nedaplatin Plus Docetaxel in the Treatment of Advanced Oesophageal Cancer: A Retrospective Study in China
Journal Title: Journal of Pharmaceutical and Biomedical Sciences - Year 2016, Vol 6, Issue 4
Abstract
Background Currently, there is no standard chemotherapy for advanced oesophageal cancer, especially for those with recurrent or metastatic one. Objective To retrospectively investigate the efficacy and safety of combination of nedaplatin with docetaxel in the treatment of Chinese patients with advanced oesophageal cancer. Methods Patients with advanced oesophageal cancer from two specialist hospitals in Guangzhou received intravenously 60 mg/m2 docetaxel for 1 h, followed by 80 mg/m2 nedaplatin for 2 h, on day 1 for every 28 days. Cycles continued until documented disease progression, unacceptable toxicity or patient’s refusal. Kaplan–Meier analysis was used to estimate survival time. Results Between 2008 and 2013, 368 patients were enrolled into the study. A total of 26 patients achieved complete response and 170 patients achieved partial response. The median of progression-free survival and overall survival were 4.4 months and 8.8 months, respectively. The non-hematological toxicities were generally mild to moderate; severe hematological toxicities included neutropenia and anaemia, which observed in 85 (23.1%) patients and 112 (30.4%) patients; thrombocytopenia was mild (mostly Grade1); there were no febrile neutropenia and treatment-related death. Conclusions The combination regimen of nedaplatin with docetaxel is effective and safe.
Authors and Affiliations
Guohua Cheng, Chongwei Chen
Keywords
Related Articles
- EP ID EP183811
- DOI -
- Views 111
- Downloads 0
Thyroid Dysfunction in Patients with Type-2 Diabetes Mellitus in Eastern India
Context To study the prevalence of thyroid dysfunction in type-2 diabetics and spectrum of thyroid dysfunction in view of importance of thyroid disorders on glycemic status and complications of diabetes mellitus (DM). Ai...
Improving Soluble Expression of Curcin-Transferrin Receptor-binding Peptide Fusion Protein with Glutathione Transferase-Small Ubiquitin-related Modifier System
Curcin can inhibit the proliferation of tumor cells and facilitate tumor cell apoptosis. In the current study, transferrin receptor (TFR)-binding peptide, TfRBP9, was fused with curcin and significantly enhanced the targ...
Effect of Dexmedetomine on Haemodynamics and Isoflorane Requirement during Laparoscopic Cholecystectomy
Minimal access surgery like laparoscopic cholecystectomy has several advantages like less pain, early mobilisation, shorten stay in hospital and better cosmetic results. Due to the haemodynamic response to pneumoperitone...
Aneurysmal Bone Cyst of Mandible: A Case Report and Review of Literature
An aneurysmal bone cyst is a rare benign expanding osteolytic lesion of bone characterized by replacement with fibro-osseous tissue containing blood filled sinusoidal or cavernous spaces of variable size. Aneurysmal bone...
Vascular Thoracic Fibrous Adipose Tissue (New Disease)
Indroduction The primary tumors of the chest wall are rare, about 2% of all cancers, and 50% are derived from soft tissue neoplasms, benign or malignant that arise at the level of the chest wall representing 2% of all ca...